Screening could help nine out of 10 patients survive bowel cancer
23 June 2009
Nine out of 10 patients will survive early stage bowel cancer if it is picked up early on, according to new research.
The findings suggest that GPs should highlight to patients the importance of taking part in bowel cancer screening when invited.
The figures are the first to be based on national statistics and are published by the National Cancer Intelligence Network (NCIN) and the Northern and Yorkshire Cancer Registry and Information Service (NYCRIS).
The NCIN looked at every case of bowel cancer diagnosed in England between 1996 and 2006 and the percentage of people that survived for at least five years.
Professor David Forman, director of NYCRIS and information lead for the NCIN, said: ‘It’s really encouraging that more people with bowel cancer will now be successfully treated, if the disease is caught at the earliest stage.
‘But overall, only half of people with bowel cancer survive, so this shows how crucial it is that the disease is spotted early.
‘More than 80% of bowel cancer cases occur in people over 60. Bowel cancer screening will be available across England for people in this age group by December 2009, and it can pick up changes that could be the earliest sign of cancer.’
sanjay.tanday@haymarket.com
Comment below and tell us what you think
Additional Information

Latest jobs Jobs web feed
- Salaried GP The Practice plc £75-85k FTE +NHS pension, Ely or Leicester
- Regional Clinical Leads The Practice plc Salary £95-105k FTE + NHS pension, Leicester or Sheffield
- Salaried/Lead GPs Malling Health Competitive, role dependant, NHS Pension and defence fees reimbursed, Nationwide
- Locums GP Wolverhampton Pegasus Medical £70 per hour, Wolverhampton and West Midlands long term
- Locum GP Leeds and Surrounding Area Pegasus Medical £70 - £75 per hour, Leeds and Yorkshire long term
- Locums GP Walsall Pegasus Medical £70 per hour, Walsall and West Midlands long term
Most read
Most commented
MIMS Drug Search
Possible searches include drugs (by brand, generic ingredient or drug class), diseases and more.







